Self-Serve Dialysis?
Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05-10-2017
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025